BACKGROUND: Families of children with cancer are confronted with a broad range of direct costs (out-of-pocket expenses), but the nature of these costs is poorly understood. This study aimed to disaggregate and describe these costs. PROCEDURE: A prospective, mixed method, cost-of-illness design was utilized. Starting in the fourth week following their child's diagnosis, parents recorded resources consumed, and costs incurred for 1 week per month for 3 consecutive months. Any additional costs not captured in this typical 1 week period were added for the remainder of the month. Parents also discussed their costs in an audio-taped interview at the end of the 3 months. Descriptive statistics and qualitative content analyses were performed to disaggregate and describe families' costs. RESULTS: In total, 99 families reported utilizing 16 cost categories and 74 cost items. Nearly three quarters of these costs were attributed to travel (56%) and food (18%). Costly items included acquisition of a car ($CAD35,000), relocation of a family ($CAD6,000), and purchase of a wheelchair ($CAD6,800). Parents described facing significant out-of-pocket expenses to ensure that their children had access to cancer treatment, to cope with the clinical treatment side effects of treatment, and to maintain the family household. CONCLUSION: Families of children with cancer experience a wide range of costs. Our understanding of the nature of their costs and resource use may formulate the basis for future cost assessments and provide insight into practice and policy changes aimed at lessening the economic impact of this burden.
BACKGROUND: Families of children with cancer are confronted with a broad range of direct costs (out-of-pocket expenses), but the nature of these costs is poorly understood. This study aimed to disaggregate and describe these costs. PROCEDURE: A prospective, mixed method, cost-of-illness design was utilized. Starting in the fourth week following their child's diagnosis, parents recorded resources consumed, and costs incurred for 1 week per month for 3 consecutive months. Any additional costs not captured in this typical 1 week period were added for the remainder of the month. Parents also discussed their costs in an audio-taped interview at the end of the 3 months. Descriptive statistics and qualitative content analyses were performed to disaggregate and describe families' costs. RESULTS: In total, 99 families reported utilizing 16 cost categories and 74 cost items. Nearly three quarters of these costs were attributed to travel (56%) and food (18%). Costly items included acquisition of a car ($CAD35,000), relocation of a family ($CAD6,000), and purchase of a wheelchair ($CAD6,800). Parents described facing significant out-of-pocket expenses to ensure that their children had access to cancer treatment, to cope with the clinical treatment side effects of treatment, and to maintain the family household. CONCLUSION: Families of children with cancer experience a wide range of costs. Our understanding of the nature of their costs and resource use may formulate the basis for future cost assessments and provide insight into practice and policy changes aimed at lessening the economic impact of this burden.
Authors: Heidi Russell; J Michael Swint; Lincy Lal; Jane Meza; David Walterhouse; Douglas S Hawkins; M Fatih Okcu Journal: Pediatr Blood Cancer Date: 2014-01-22 Impact factor: 3.167
Authors: Mark N Fluchel; Anne C Kirchhoff; Julia Bodson; Carol Sweeney; Sandra L Edwards; Qian Ding; Gregory J Stoddard; Anita Y Kinney Journal: Pediatr Blood Cancer Date: 2014-08-17 Impact factor: 3.167
Authors: Heidi V Russell; Yueh-Yun Chi; M Fatih Okcu; M Brooke Bernhardt; Carlos Rodriguez-Galindo; Abha A Gupta; Douglas S Hawkins Journal: Cancer Date: 2021-10-08 Impact factor: 6.860
Authors: Sapna Kaul; Ernest Kent Korgenski; Jian Ying; Christi F Ng; Rochelle R Smits-Seemann; Richard E Nelson; Seth Andrews; Elizabeth Raetz; Mark Fluchel; Richard Lemons; Anne C Kirchhoff Journal: Cancer Med Date: 2015-12-29 Impact factor: 4.452
Authors: Latha M Sneha; Jeyanth Sai; S Ashwini; Sunitha Ramaswamy; Mahalakshmi Rajan; Julius X Scott Journal: Indian J Med Paediatr Oncol Date: 2017 Jan-Mar